Noboru Imai

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Fumihiko Sakai, Norihiro Suzuki, Byung‐Kun Kim et al. · Headache The Journal of Head and Face Pain · 2021 · 107 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study

Takao Takeshima, Fumihiko Sakai, Koichi Hirata et al. · Headache The Journal of Head and Face Pain · 2021 · 103 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Clinical profile of cluster headaches in Japan: Low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessness

Noboru Imai, Nobuyasu Yagi, Ryou Kuroda et al. · Cephalalgia · 2011 · 75 citations · Full text

Medicine, Neurology, Psychiatry +8

The TriAGe+ Score for Vertigo or Dizziness: A Diagnostic Model for Stroke in the Emergency Department

Ryosuke Kuroda, Takeo Nakada, Toshiyuki Ojima et al. · Journal of Stroke and Cerebrovascular Diseases · 2017 · 61 citations · Full text

Medicine, Emergency Medicine, Neurology +14

Clinicopathologic Features of Oculopharyngodistal Myopathy With<i>LRP12</i>CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes

Theerawat Kumutpongpanich, Masashi Ogasawara, Ayami Ozaki et al. · JAMA Neurology · 2021 · 55 citations · Full text

Medicine, Pathobiology, Pathology +9